AZIERTA Launches the “Pro-Bone-Covid-19 Program”
The consultancy firm AZIERTA provides Spanish and European researchers with its resources to promote the fight against the coronavirus pandemic
It offers all its support, through the “pro-bono” program, to any of the actors involved in winning the battle of COVID-19
AZIERTA, a global science and health consultancy firm specialised in the development of drugs and health products from a clinical, regulatory, safety and quality point of view, launches its “PRO-BONO-COVID-19 PROGRAM”.
As part of its social commitment, it has launched the “Pro-Bono Programme”, a programme aimed at researchers to tackle the COVID-19 pandemic. AZIERTA, a national and international reference in global and comprehensive scientific consultancy, offers researchers in Spain and Europe all the skills and experience required to accelerate the development and approval processes for drugs and medical devices that can help to combat COVID-19.
Faced with this serious health situation, the Consultant offers its resources to win the battle against the coronavirus. The assistance of a group of knowledgeable professionals involved in the sector, plus the research of scientific experts, will forge a perfect symbiosis of knowledge transfer and research momentum to advance against the impact of the COVID-19 virus.
Therefore, AZIERTA provides all interested research groups with an urgent contact mailbox through its digital platform https://www.azierta.com/ for the implementation, development and approval of medicines, medical devices or any other clinical, epidemiological or observational development that could be useful in the fight against this pandemic.
AZIERTA will offer “pro-bono” all its support to any of the actors involved in the fight against COVID-19, whether they are private promoters, public entities, agencies, governments, etc., joining in a totally altruistic way, with all its forces and resources, to the common fight of our society against this global pandemic.